The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ONC FINANCIAL STATEMENTS

BeiGene, Ltd. — balance sheet, income statement and cash flow trends

ONCBeiGene, Ltd.

🇺🇸 USA · US · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income
-2.5 B02.5 B5 B202120222023202420252026

Profit Funnel

Q1 2026 · TTM
Revenue5.7 B $Gross Profit5.1 B $ · 88%Operating Income685.9 M $ · 12%Pre-tax Income655.2 M $ · 11%Net Income513 M $ · 9%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue5.7 B $+37.4%
Gross Profit5.1 B $+43.1%
Operating Income685.9 M $—
EBITDA901.8 M $—
Net Income513 M $—

Peer Comparison· Biotechnology

CompanyRev. GrowthGross MarginEBITDA MarginNet Margin
ONC37.4%88.3%15.7%8.9%
Industry median4.1%84.0%-105.8%-125.7%

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02.5 B5 B7.5 B202120222023202420252026

Capital Structure

Q1 2026
Total Assets8.6 B
  • Equity4.8 B $56%
  • Current Liabilities1.8 B $21%
  • Long-term Liabilities2 B $23%

Key Figures

YoY change
Total Assets8.6 B $+46.4%
Total Liabilities3.8 B $+62.0%
Total Equity4.8 B $+36.0%
Cash & ST Investments4.8 B $+90.4%
Total Debt1.1 B $+15.3%
Net Debt-3.6 B $—

Peer Comparison· Biotechnology

CompanyCurrent RatioDebt/EquityNetDebt/EBITDAEquity/Assets
ONC3.6424.1%-4.0455.7%
Industry median5.9010.9%1.1570.0%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-2 B-1 B01 B202120222023202420252026

Cash Flow Bridge

Q1 2026 · TTM
01 B2 B1.3 B $Operating-200.1 M $Investing1.2 B $Financing2.2 B $Net Change

Key Figures

YoY change
Operating Cash Flow1.3 B $+506.3%
Capital Expenditures438.9 M $-3.0%
Free Cash Flow846.5 M $—
Dividends Paid——

Peer Comparison· Biotechnology

CompanyCF MarginFCF MarginCapEx RatioCF/Net Income
ONC22.4%14.8%7.6%250.6%
Industry median-88.0%-90.9%1.9%81.5%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ONC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. This content is for informational purposes only and is not investment advice.